Candel Therapeutics, Inc. CADL
11.02
(0.53)
(4.59%)
as of 25 Sep
- Market cap
- $883.8M
- P/E
- 0.0×
Follow CADL
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | — |
+8 more quarters Free account |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
15.89 | 27.63 | 13.31 | 7.96 | |
Current Ratio |
16.09 | 28.05 | 13.49 | 8.25 | |
Net Debt/EBITDA |
5.78 | 9.13 | 4.66 | 6.28 | |
Debt/Assets |
22.98% | 23.51% | 37.65% | 5.55% | |
Debt/Equity |
0.38 | 0.34 | 0.91 | 0.06 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.44 | 2.04 | 0.36 | 0.91 | |
Capex/Depreciation |
(0.40) | (4.53) | (2.51) | (0.60) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.23) | (0.29) | (0.20) | (0.19) | |
Capex per Share |
0.00 | (0.01) | (0.01) | 0.00 | |
Free Cash Flow per Share |
(0.23) | (0.30) | (0.21) | (0.19) | |
Cash per Share |
2.72 | 3.12 | 2.26 | 1.58 | |
Shareholders Equity per Share |
1.70 | 2.21 | 0.98 | 1.46 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.70 | 2.21 | 0.98 | 1.46 | |
Free Cash Flow |
(17.25) | (18.71) | (10.98) | (10.35) | |
Working Capital |
191.47 | 190.70 | 112.39 | 79.21 | |
Capital Expenditures |
(0.07) | (0.67) | (0.41) | (0.12) | |
Net Current Asset Value |
122.14 | 133.86 | 48.12 | 76.66 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Payables |
3.55 | 1.90 | 0.68 | 0.71 | |
Average Assets |
157.06 | 148.91 | 116.03 | 57.56 | |
Average Common Equity |
108.17 | 106.35 | 59.12 | 32.43 |
Columns are period end dates